Menu Back to 3rd-DIA-CMC-Forum-in-Japan

Program Committee

  • Fusashi  Ishikawa, PhD, MSc
    Fusashi Ishikawa, PhD, MSc Director, Formulation Property Research Group, Formulation R&D Laboratories
    Sumitomo Dainippon Pharma Co., Ltd., Japan
  • Takeshi  Hishikura
    Takeshi Hishikura Director, International Affairs
    Japan Generic Medicines Association, Japan
  • Yukio  Hiyama, PhD
    Yukio Hiyama, PhD Visiting Researcher
    National Institute of Health Sciences, Japan
  • Noriko  Katori, PhD
    Noriko Katori, PhD Division of Drugs
    National Institute of Health Sciences, Japan
  • Yoshihiro  Matsuda, PhD
    Yoshihiro Matsuda, PhD Senior Scientist (for Quality)
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Satoshi  Nagayama
    Satoshi Nagayama Principal Scientist
    Pfizer Japan Inc., Japan
  • Kazuhiro  Okochi
    Kazuhiro Okochi Associate Director, GMS Japan Quality Center
    Takeda Pharmaceutical Company Limited, Japan
  • Haruhiro  Okuda, PhD
    Haruhiro Okuda, PhD Deputy Director General
    National Institute of Health Sciences, Japan
  • Rumiko  Shimazawa, PhD
    Rumiko Shimazawa, PhD Professor, Clinical Pharmacology
    Tokai University School of Medicine, Japan
  • Nobuyuki  Suzuki, PhD
    Nobuyuki Suzuki, PhD Representative Director
    Kan-I Net, Japan
Load More